Axa’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,218
Closed -$2.57M 1400
2018
Q3
$2.57M Hold
2,218
0.01% 830
2018
Q2
$1.9M Buy
2,218
+28
+1% +$23.3K 0.01% 864
2018
Q1
$2.57M Sell
2,190
-21
-0.9% -$23.2K 0.01% 805
2017
Q4
$2.04M Sell
2,211
-2
-0.1% -$1.85K 0.01% 855
2017
Q3
$2.43M Sell
2,213
-30
-1% -$34.1K 0.01% 780
2017
Q2
$2.58M Sell
2,243
-80
-3% -$97.4K 0.01% 740
2017
Q1
$2.68M Sell
2,323
-75
-3% -$72.4K 0.01% 719
2016
Q4
$2.53M Sell
2,398
-3,035
-56% -$1.38M 0.01% 713
2016
Q3
$2.17M Buy
5,433
+4
+0.1% +$1.63K 0.01% 742
2016
Q2
$2.24M Buy
5,429
+75
+1% +$36.7K 0.01% 723
2016
Q1
$2.29M Hold
5,354
0.01% 726
2015
Q4
$3.08M Sell
5,354
-113
-2% -$79.2K 0.01% 687
2015
Q3
$4.87M Buy
5,467
+619
+13% +$564K 0.02% 579
2015
Q2
$4.99M Buy
4,848
+757
+19% +$887K 0.02% 599
2015
Q1
$5.83M Buy
4,091
+1,503
+58% +$1.91M 0.02% 553
2014
Q4
$3.62M Buy
2,588
+165
+7% +$238K 0.01% 642
2014
Q3
$2.96M Sell
2,423
-15
-0.6% -$21.6K 0.01% 653
2014
Q2
$4.44M Buy
2,438
+975
+67% +$1.3M 0.02% 579
2014
Q1
$2.38M Buy
+1,463
New +$3.06M 0.01% 722

Other funds holding HSTO

Axa's HSTO Position: Q4 2018 in Review

Axa sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 2,218 shares — an estimated $2.57M sold.

Axa first reported a position in HSTO in Q1 2014 and held it in 19 quarters. The position peaked at $5.83M in Q1 2015. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

  • Axa reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Axa sold 2,218 Histogen Inc. Common Stock shares in Q4 2018, an estimated $2.57M.
  • Axa first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 19 quarters.
  • Axa's Histogen Inc. Common Stock position peaked at $5.83M in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.